IBRX
NASDAQ HealthcareImmunityBio, Inc. - Common Stock
Biotechnology
ImmunityBio, Inc., a biotechnology company, focuses on innovating, developing, and commercializing next-generation immunotherapies designed to activate the patient's immune system and deliver durable protection against cancer and infectious diseases. Its platforms for the development of biologic products and product candidates that include cytokine fusion proteins, DNA and vaccine vectors, and cell therapies. The company's platform has generated first-in-human therapeutic agents that are planned to be studied in clinical trials in liquid and solid tumors. Its lead biologic product candidate includes Anktiva, an FDA-approved immunotherapy in combination with bacillus calmette-guรฉrin (BCG) for the treatment of adult patients with BCG unresponsive non-muscle invasive bladder cancer with carcinoma in situ, with or without papillary tumors; and 3M-052, a synthetic TLR7/8 agonist and 3M-052 formulations and related technology. The company has collaboration agreements with National Cancer Institute; Serum Institute of India Private Limited; and BeOne Medicines Ltd. It has license agreement with 3M Innovative Properties Company and Access to Advanced Health Institute. ImmunityBio, Inc. is based in San Diego, California.
๐ Market Data
| Price | $7.11 |
|---|---|
| Volume | 7,618,968 |
| Market Cap | 7.34B |
| Beta | 0.060 |
| RSI (14-Day) | 47.4 |
| 200-Day MA | $4.30 |
| 50-Day MA | $8.13 |
| 52-Week High | $12.43 |
| 52-Week Low | $1.83 |
| Forward P/E | -355.50 |
| Price / Book | -14.36 |
๐ฏ Investment Strategy Scores
IBRX scores across each investment strategy. Higher is better for that strategy's goals.
๐ Strategy Interpretation
Best fit: ๐ Institutional Whale (67/100) โ this strategy Large-cap, institutional-quality stocks.
Lowest fit among scored strategies: ๐ช Falling Knife (17/100). No single score is a buy or sell signal โ use multiple lenses together. Learn how to read these scores โ
๐ Learn More
Indicators on this page
Educational articles
Find IBRX in your text
Paste any article, transcript, or post โ the tool will extract IBRX and every other hidden ticker.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-05-01.